A high density of B cells within a TLS is positively correlated with tumor antigen-specific antibody responses and increased intratumor CD4+ T cell clonality as well as early differentiated, activated, and non-regulatory CD4+ T cells, suggesting a central role of B cells in determining protective T cell responses in NSCLC patients [29,30]. Here, CD4 is linked to neoplasm.